MedPath

effect of Omega 3 on UTI

Phase 3
Recruiting
Conditions
rinary tract infection.
Urinary tract infection, site not specified
N39.0
Registration Number
IRCT20191104045328N22
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Children 4-18 years old with urinary tract infection
Consent to participate in the study

Exclusion Criteria

The presence of underlying kidney and liver disease
Sensitivity to omega-3

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.